Clinical trial
Assessment of Tolerability & Effectiveness of Progut in Treatment of Irritable Bowel Syndrome
NCT00904696 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Tolerability & Effectiveness of Progut in Treatment of Irritable Bowel Syndrome
- Lead sponsor
- National University Hospital, Singapore
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- September 30, 2009
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
irritable bowel syndrome (ibs)